Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

LAVA Therapeutics N.V. LVTX

Set alert

Price alert · LVTX

All alert types
1.74 0.00 0.00%

At close · Nov 28

1.74 Day range 1.74

52-week range unavailable

YTD
+82.97%
1 year
+8.75%
Open
1.74
Prev close
1.74
Mkt cap
45.77M
Vol
285.52K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.74
High
1.74
Forward P/E
-0.51
Beta
0.48
Short ratio
0.41
Inst. own
31.88%
Dividend
0.00
Ex-div date
Earnings
Aug 20, 2024
50-d avg
1.63
200-d avg
2.12
1y target
2.32

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for LVTX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 2.32 +33.5% upside
Target (low)
1.99
Target (mean)
2.32
Target (high)
2.98
Ratings (0m) 4 2 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LVTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.2675-0.371 – -0.164-0.22099-21.0%2.40M+637.2%2
Next quarter-0.3445-0.352 – -0.337-0.01842-1770.3%0-100.0%2
Current year-1.02-1.12 – -0.915-1.45+29.5%7.41M+18.9%2
Next year-1.40-1.44 – -1.36-1.02-37.1%0-100.0%2

Upgrades and downgrades

The latest rating changes

LVTX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 20, 2024HC Wainwright & Co.MaintainedBuyBuy
Dec 12, 2024Leerink PartnersDowngradeOutperformMarket Perform
Dec 11, 2024JMP SecuritiesDowngradeMarket OutperformMarket Perform
Aug 21, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Jun 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 19, 2021JefferiesInitiated—Buy
Apr 19, 2021JP MorganInitiated—Overweight
Apr 19, 2021SVB LeerinkInitiated—Outperform